FilingReader Intelligence
3SBio raises HK$785m from Pfizer share subscription
August 1, 2025 at 09:23 AM UTC•By FilingReader AI
3SBio Inc raised HK$785 million by issuing 31.1 million shares to Pfizer at HK$25.21 per share.
The proceeds will fund global research and development (80%) and general corporate purposes (20%). The subscription gives Pfizer a 1.28% stake in the enlarged share capital.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
News Alerts
Get instant email alerts when 3SBio Inc publishes news
Free email notifications • Unsubscribe anytime